Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178354 | SCV000230420 | uncertain significance | not provided | 2014-11-14 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000548844 | SCV000630844 | likely pathogenic | Walker-Warburg congenital muscular dystrophy | 2023-03-09 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FKRP protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. ClinVar contains an entry for this variant (Variation ID: 197342). This missense change has been observed in individual(s) with clinical features of limb girdle muscular dystrophy (PMID: 18832576, 24257234, 32429923; Invtiae, external communication). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 196 of the FKRP protein (p.Gly196Arg). |
Counsyl | RCV000674993 | SCV000800415 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2018-06-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492782 | SCV002789518 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1; Muscular dystrophy-dystroglycanopathy type B5; Autosomal recessive limb-girdle muscular dystrophy type 2I; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2021-09-01 | criteria provided, single submitter | clinical testing |